AIM ImmunoTech's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; AIM ImmunoTech is scheduled to report earnings on May 16, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 42.00K	$ 49.00K	$ 57.00K	$ 21.00K	$ 30.00K
Gross Profit	$ 42.00K	$ 49.00K	$ 203.00K	$ 21.00K	$ -39.00K
EBIT	$ -5.24M	$ 4.77M	$ -5.00M	$ -6.38M	$ -4.85M
EBITDA	$ -5.16M	$ 4.82M	$ -4.83M	$ -6.36M	$ -4.82M
Net Income Common Stockholders	$ -4.91M	$ 5.03M	$ -4.39M	$ -6.38M	$ -4.85M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 28.40M	$ 30.85M	$ 34.19M	$ 36.74M	$ 41.77M
Total Assets	$ 33.62M	$ 37.31M	$ 40.49M	$ 46.28M	$ 50.88M
Total Debt	$ 803.00K	$ 814.00K	$ 837.00K	$ 866.00K	$ 889.00K
Net Debt	$ -27.59M	$ -30.04M	$ -33.35M	$ -35.88M	$ -40.88M
Total Liabilities	$ 3.48M	$ 2.47M	$ 2.02M	$ 3.59M	$ 2.10M
Stockholders Equity	$ 30.14M	$ 34.99M	$ 38.47M	$ 42.70M	$ 48.78M
Cash Flow	-
Free Cash Flow	$ -2.21M	$ -3.63M	$ -2.64M	$ -4.99M	$ -2.36M
Operating Cash Flow	$ -2.16M	$ -3.66M	$ -6.07M	$ -4.97M	$ -2.31M
Investing Cash Flow	$ -204.00K	$ -78.00K	$ 3.36M	$ 250.00K	$ 7.72M
Financing Cash Flow	$ 5.00K	$ 100.00K	-	$ 25.00K	$ 55.00K

Currency in USD

AIM ImmunoTech Earnings and Revenue History

Income Statement >

AIM ImmunoTech Debt to Assets

Balance Sheet >

AIM ImmunoTech Cash Flow

Cash Flow >

AIM ImmunoTech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing